Investigating new treatments for rare skin lymphomas
A fusion protein therapy may be an effective treatment option for cutaneous T-cell lymphomas, according to a multicenter ...
The American Journal of Managed Care17h
Combination Immunotherapy Offers New Pathway for Skin Cancer Prevention
A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer ...
lupusnewstoday4d
Caribou Phase 1 trial testing safety, efficacy of CAR T-cell therapy
Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...
clinicalpainadvisor.com4d
Connective Tissue Disease Treatments Affect COVID-19 Hospitalization and Morality
Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with ...
healthday5d
Risk for Atherosclerotic CVD Up in Association With Cutaneous Lupus Erythematosus
Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease ...
healthday5d
People With Lupus Are At Risk for This Type of Heart Disease
People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the a ...
8 Autoimmune Diseases You May Not Know Are Linked to Hair Loss
You might associate autoimmune conditions with symptoms like skin disease, chronic pain, and fatigue. A less-discussed ...
Lupus Foundation of America6d
UPDATE: Phase 1 Trial Begins for Investigational Therapy, CB-010, for Lupus Nephritis Treatment
The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.